We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Mantle Cell Lymphoma Treatment by RiBVD (RIBVD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01457144
Recruitment Status : Completed
First Posted : October 21, 2011
Last Update Posted : March 16, 2016
Lymphoma Study Association
Janssen-Cilag Ltd.
Mundipharma Pte Ltd.
Roche Pharma AG
Chugai Pharma Europe Ltd.
Information provided by (Responsible Party):
French Innovative Leukemia Organisation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2014
  Study Completion Date : March 2016